Biomarkers are objective indicators used to assess normal or pathological processes,
evaluate responses to treatment and predict outcomes. Many blood biomarkers already …

712 Stroke March 2020 outcome of stroke. 27, 28 Rosuvastatin reduced stroke risk in
subjects who either achieved LDL-C levels of< 70 mg/dL or hs-CRP levels of< 2 mg/L …

Objectives To assess the efficacy and safety of colchicine versus placebo on reducing the
risk of subsequent stroke after high risk non-cardioembolic ischaemic stroke or transient …

Objective Contribution of individual and combined inflammatory markers in prognosis after
stroke was still undefined. We aimed to investigate the association of systemic and local …

Atherosclerosis is a chronic inflammatory disease of the vascular system that is
characterized by the deposition of modified lipoproteins, accumulation of immune cells, and …

Background and Objectives Anti-inflammatory therapies reduce major adverse
cardiovascular events (MACE) in coronary artery disease but remain unproven after stroke …

Background and Purpose: It is still unclear whether the residual cholesterol and
inflammatory risk in the acute phase is associated with prognosis of stroke. We aimed to …

Background: Insulin resistance is associated with stroke recurrence and poor functional
outcomes of nondiabetic patients with ischemic stroke. The study aimed to investigate …

Background Recent randomised trials showed benefit for anti-inflammatory therapies in
coronary disease but excluded stroke. The prognostic value of blood inflammatory markers …

Stroke is a major cause of neurological morbidity and mortality. Atherosclerosis is a major
contributor to first and recurrent stroke. A growing evidence base indicates that inflammation …